<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35947700</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1362-4962</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>16</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>09</Day></PubDate></JournalIssue><Title>Nucleic acids research</Title><ISOAbbreviation>Nucleic Acids Res</ISOAbbreviation></Journal><ArticleTitle>Biochemical and structural characterization of hepatitis A virus 2C reveals an unusual ribonuclease activity on single-stranded RNA.</ArticleTitle><Pagination><StartPage>9470</StartPage><EndPage>9489</EndPage><MedlinePgn>9470-9489</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/nar/gkac671</ELocationID><Abstract><AbstractText>The HAV nonstructural protein 2C is essential for virus replication; however, its precise function remains elusive. Although HAV 2C shares 24-27% sequence identity with other 2Cs, key motifs are conserved. Here, we demonstrate that HAV 2C is an ATPase but lacking helicase activity. We identified an ATPase-independent nuclease activity of HAV 2C with a preference for polyuridylic single-stranded RNAs. We determined the crystal structure of an HAV 2C fragment to 2.2 Å resolution, containing an ATPase domain, a region equivalent to enterovirus 2C zinc-finger (ZFER) and a C-terminal amphipathic helix (PBD). The PBD of HAV 2C occupies a hydrophobic pocket (Pocket) in the adjacent 2C, and we show the PBD-Pocket interaction is vital for 2C functions. We identified acidic residues that are essential for the ribonuclease activity and demonstrated mutations at these sites abrogate virus replication. We built a hexameric-ring model of HAV 2C, revealing the ribonuclease-essential residues clustering around the central pore of the ring, whereas the ATPase active sites line up at the gaps between adjacent 2Cs. Finally, we show the ribonuclease activity is shared by other picornavirus 2Cs. Our findings identified a previously unfound activity of picornavirus 2C, providing novel insights into the mechanisms of virus replication.</AbstractText><CopyrightInformation>© The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Pu</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wojdyla</LastName><ForeName>Justyna Aleksandra</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Swiss Light Source at the Paul Scherrer Institute, CH-5232 Villigen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colasanti</LastName><ForeName>Ombretta</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>University of Heidelberg, Department of Infectious Diseases, Molecular Virology Centre for Integrative Infectious Disease Research (CIID) INF 344, 1st. Floor, D-69120 Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhijian</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Meitian</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Swiss Light Source at the Paul Scherrer Institute, CH-5232 Villigen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lohmann</LastName><ForeName>Volker</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>University of Heidelberg, Department of Infectious Diseases, Molecular Virology Centre for Integrative Infectious Disease Research (CIID) INF 344, 1st. Floor, D-69120 Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Sheng</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6329-3582</Identifier><AffiliationInfo><Affiliation>NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, PR China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nucleic Acids Res</MedlineTA><NlmUniqueID>0411011</NlmUniqueID><ISSNLinking>0305-1048</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="D000251">Adenosine Triphosphatases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.-</RegistryNumber><NameOfSubstance UI="D012260">Ribonucleases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D030041" MajorTopicYN="Y">Hepatitis A virus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010849" MajorTopicYN="Y">Picornaviridae</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000251" MajorTopicYN="N">Adenosine Triphosphatases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012260" MajorTopicYN="N">Ribonucleases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>10</Day><Hour>14</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35947700</ArticleId><ArticleId IdType="pmc">PMC9458454</ArticleId><ArticleId IdType="doi">10.1093/nar/gkac671</ArticleId><ArticleId IdType="pii">6659853</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>International Committee on Taxonomy of Viruses Virus Taxonomy: Classification and Nomenclature of Viruses: Sixth Report of the International Committee on Taxonomy of Viruses. 1995; NY: Springer-Verlag Wien Austria.</Citation></Reference><Reference><Citation>Lemon S.M., Ott J.J., Van Damme P., Shouval D.. Type a viral hepatitis: a summary and update on the molecular virology, epidemiology, pathogenesis and prevention. J. Hepatol. 2017; 68:167–184.</Citation><ArticleIdList><ArticleId IdType="pubmed">28887164</ArticleId></ArticleIdList></Reference><Reference><Citation>Averhoff F.M., Khudyakov Y., Nelson N.P.. Plotkin S.A., Orenstein W.A., Offit P.A., Edwards K.M.. 24 - Hepatitis A Vaccines. Plotkin's Vaccines. 7th edn. 2018; Elsevier; 319–341.</Citation></Reference><Reference><Citation>Foster M.A., Hofmeister M.G., Kupronis B.A., Lin Y., Xia G.L., Yin S., Teshale E.. Increase in hepatitis a virus infections - United States, 2013-2018. MMWR Morb. Mortal. Wkly. Rep. 2019; 68:413–415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6542191</ArticleId><ArticleId IdType="pubmed">31071072</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X., Collier M.G., Xu F.. Hepatitis a outbreaks in developed countries: detection, control, and prevention. Foodborne Pathog Dis. 2020; 17:166–171.</Citation><ArticleIdList><ArticleId IdType="pubmed">31829731</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuart D.I., Ren J., Wang X., Rao Z., Fry E.E.. Hepatitis a virus capsid structure. Cold Spring Harb Perspect Med. 2019; 9:a031807.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6496327</ArticleId><ArticleId IdType="pubmed">30037986</ArticleId></ArticleIdList></Reference><Reference><Citation>Debing Y., Neyts J., Thibaut H.J.. Molecular biology and inhibitors of hepatitis a virus. Med. Res. Rev. 2014; 34:895–917.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7168461</ArticleId><ArticleId IdType="pubmed">23722879</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia X.Y., Summers D.F., Ehrenfeld E.. Primary cleavage of the HAV capsid protein precursor in the middle of the proposed 2A coding region. Virology. 1993; 193:515–519.</Citation><ArticleIdList><ArticleId IdType="pubmed">8382411</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusov Y., Gauss-Muller V.. Improving proteolytic cleavage at the 3A/3B site of the hepatitis a virus polyprotein impairs processing and particle formation, and the impairment can be complemented in trans by 3AB and 3ABC. J. Virol. 1999; 73:9867–9878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC113036</ArticleId><ArticleId IdType="pubmed">10559299</ArticleId></ArticleIdList></Reference><Reference><Citation>Gosert R., Egger D., Bienz K.. A cytopathic and a cell culture adapted hepatitis a virus strain differ in cell killing but not in intracellular membrane rearrangements. Virology. 2000; 266:157–169.</Citation><ArticleIdList><ArticleId IdType="pubmed">10612670</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuechler E., Seipelt J., Liebig H.-D., Sommergruber W.. Semler B., Wimmer E.. Picornavirus Proteinase-Mediated Shutoff of Host Cell Translation: Direct Cleavage of a Cellular Initiation Factor. Molecular Biology of Picornavirus. 2002; Wiley; 299–311.</Citation></Reference><Reference><Citation>Pinto R.M., Aragones L., Costafreda M.I., Ribes E., Bosch A.. Codon usage and replicative strategies of hepatitis a virus. Virus Res. 2007; 127:158–163.</Citation><ArticleIdList><ArticleId IdType="pubmed">17524513</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusov Y.Y., Probst C., Jecht M., Jost P.D., Gauss-Muller V.. Membrane association and RNA binding of recombinant hepatitis a virus protein 2C. Arch. Virol. 1998; 143:931–944.</Citation><ArticleIdList><ArticleId IdType="pubmed">9645199</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P., Li Z., Cui S.. Cameron C.E., Arnold J.J., Kaguni L.S.. Chapter Nine -Picornaviral 2C proteins: An unique ATPase family critical in virus replication. The Enzyme. 2021; 49:Elsevier; 235–264.</Citation><ArticleIdList><ArticleId IdType="pubmed">34696834</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi M.S., Walimbe A.M., Chitambar S.D.. Evaluation of genomic regions of hepatitis a virus for phylogenetic analysis: suitability of the 2C region for genotyping. J. Virol. Methods. 2008; 153:36–42.</Citation><ArticleIdList><ArticleId IdType="pubmed">18619492</ArticleId></ArticleIdList></Reference><Reference><Citation>Teterina N.L., Bienz K., Egger D., Gorbalenya A.E., Ehrenfeld E.. Induction of intracellular membrane rearrangements by HAV proteins 2C and 2BC. Virology. 1997; 237:66–77.</Citation><ArticleIdList><ArticleId IdType="pubmed">9344908</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Liang Y., Qu L., Chen Z., Yi M., Li K., Lemon S.M.. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc. Natl. Acad. Sci. U.S.A. 2007; 104:7253–7258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1855380</ArticleId><ArticleId IdType="pubmed">17438296</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger D., Bienz K.. Intracellular location and translocation of silent and active poliovirus replication complexes. J. Gen. Virol. 2005; 86:707–718.</Citation><ArticleIdList><ArticleId IdType="pubmed">15722531</ArticleId></ArticleIdList></Reference><Reference><Citation>Singleton M.R., Dillingham M.S., Wigley D.B.. Structure and mechanism of helicases and nucleic acid translocases. Annu. Rev. Biochem. 2007; 76:23–50.</Citation><ArticleIdList><ArticleId IdType="pubmed">17506634</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H., Wang P., Wang G.C., Yang J., Sun X., Wu W., Qiu Y., Shu T., Zhao X., Yin L.et al. .. Human enterovirus nonstructural protein 2CATPase functions as both an RNA helicase and ATP-Independent RNA chaperone. PLoS Pathog. 2015; 11:e1005067.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4517893</ArticleId><ArticleId IdType="pubmed">26218680</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee R., Dasgupta A.. Interaction of picornavirus 2C polypeptide with the viral negative-strand RNA. J. Gen. Virol. 2001; 82:2621–2627.</Citation><ArticleIdList><ArticleId IdType="pubmed">11602773</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan H., Tian J., Qin B., Wojdyla J.A., Wang B., Zhao Z., Wang M., Cui S.. Crystal structure of 2C helicase from enterovirus 71. Sci. Adv. 2017; 3:e1602573.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5409451</ArticleId><ArticleId IdType="pubmed">28508043</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan H., Tian J., Zhang C., Qin B., Cui S.. Crystal structure of a soluble fragment of poliovirus 2CATPase. PLoS Pathog. 2018; 14:e1007304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6166989</ArticleId><ArticleId IdType="pubmed">30231078</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney T.R., Cisnetto V., Bose D., Bailey M., Wilson J.R., Zhang X., Belsham G.J., Curry S.. Foot-and-mouth disease virus 2C is a hexameric AAA+ protein with a coordinated ATP hydrolysis mechanism. J. Biol. Chem. 2010; 285:24347–24359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2915670</ArticleId><ArticleId IdType="pubmed">20507978</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinert T., Olieric V., Waltersperger S., Panepucci E., Chen L., Zhang H., Zhou D., Rose J., Ebihara A., Kuramitsu S.et al. .. Fast native-SAD phasing for routine macromolecular structure determination. Nat. Methods. 2015; 12:131–133.</Citation><ArticleIdList><ArticleId IdType="pubmed">25506719</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheldrick G.M. Experimental phasing with SHELXC/D/E: combining chain tracing with density modification. Acta Crystallogr. D Biol. Crystallogr. 2010; 66:479–485.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2852312</ArticleId><ArticleId IdType="pubmed">20383001</ArticleId></ArticleIdList></Reference><Reference><Citation>Emsley P., Lohkamp B., Scott W.G., Cowtan K.. Features and development of coot. Acta Crystallogr. D Biol. Crystallogr. 2010; 66:486–501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2852313</ArticleId><ArticleId IdType="pubmed">20383002</ArticleId></ArticleIdList></Reference><Reference><Citation>McCoy A.J., Grosse-Kunstleve R.W., Adams P.D., Winn M.D., Storoni L.C., Read R.J.. Phaser crystallographic software. J. Appl. Crystallogr. 2007; 40:658–674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2483472</ArticleId><ArticleId IdType="pubmed">19461840</ArticleId></ArticleIdList></Reference><Reference><Citation>Liebschner D., Afonine P.V., Baker M.L., Bunkoczi G., Chen V.B., Croll T.I., Hintze B., Hung L.W., Jain S., McCoy A.J.et al. .. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in phenix. Acta Crystallogr. D Struct. Biol. 2019; 75:861–877.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6778852</ArticleId><ArticleId IdType="pubmed">31588918</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao W., Wojdyla J.A., Zhao R., Han R., Das R., Zlatev I., Manoharan M., Wang M., Cui S.. Crystal structure of middle east respiratory syndrome coronavirus helicase. PLoS Pathog. 2017; 13:e1006474.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5501694</ArticleId><ArticleId IdType="pubmed">28651017</ArticleId></ArticleIdList></Reference><Reference><Citation>Esser-Nobis K., Harak C., Schult P., Kusov Y., Lohmann V.. Novel perspectives for hepatitis a virus therapy revealed by comparative analysis of hepatitis c virus and hepatitis a virus RNA replication. Hepatology. 2015; 62:397–408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7165973</ArticleId><ArticleId IdType="pubmed">25866017</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Hoff M.J., Moorman A.F., Lamers W.H.. Electroporation in ‘intracellular’ buffer increases cell survival. Nucleic Acids Res. 1992; 20:2902.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC336954</ArticleId><ArticleId IdType="pubmed">1614888</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauss-Muller V., Kusov Y.Y.. Replication of a hepatitis a virus replicon detected by genetic recombination in vivo. J. Gen. Virol. 2002; 83:2183–2192.</Citation><ArticleIdList><ArticleId IdType="pubmed">12185272</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez P.L., Carrasco L.. Poliovirus protein 2C has ATPase and GTPase activities. J. Biol. Chem. 1993; 268:8105–8110.</Citation><ArticleIdList><ArticleId IdType="pubmed">8385138</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams P., Kandiah E., Effantin G., Steven A.C., Ehrenfeld E.. Poliovirus 2C protein forms homo-oligomeric structures required for ATPase activity. J. Biol. Chem. 2009; 284:22012–22021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2755925</ArticleId><ArticleId IdType="pubmed">19520852</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J.I., Ticehurst J.R., Purcell R.H., Buckler-White A., Baroudy B.M.. Complete nucleotide sequence of wild-type hepatitis a virus: comparison with different strains of hepatitis a virus and other picornaviruses. J. Virol. 1987; 61:50–59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC255199</ArticleId><ArticleId IdType="pubmed">3023706</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon-Robarts M., Blouin A.G., Bleker S., Kleinschmidt J.A., Aggarwal A.K., Escalante C.R., Linden R.M.. Residues within the B' motif are critical for DNA binding by the superfamily 3 helicase rep40 of adeno-associated virus type 2. J. Biol. Chem. 2004; 279:50472–50481.</Citation><ArticleIdList><ArticleId IdType="pubmed">15371437</ArticleId></ArticleIdList></Reference><Reference><Citation>Holm L. DALI and the persistence of protein shape. Protein Sci. 2020; 29:128–140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6933842</ArticleId><ArticleId IdType="pubmed">31606894</ArticleId></ArticleIdList></Reference><Reference><Citation>Laufman O., Perrino J., Andino R.. Viral generated inter-organelle contacts redirect lipid flux for genome replication. Cell. 2019; 178:275–289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7077330</ArticleId><ArticleId IdType="pubmed">31204099</ArticleId></ArticleIdList></Reference><Reference><Citation>Minskaia E., Hertzig T., Gorbalenya A.E., Campanacci V., Cambillau C., Canard B., Ziebuhr J.. Discovery of an RNA virus 3′→5′ exoribonuclease that is critically involved in coronavirus RNA synthesis. Proc. Natl. Acad. Sci. U.S.A. 2006; 103:5108–5113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1458802</ArticleId><ArticleId IdType="pubmed">16549795</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima W.F., Crooke S.T.. Binding affinity and specificity of escherichia coli RNase H1: impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybrids. Biochemistry. 1997; 36:390–398.</Citation><ArticleIdList><ArticleId IdType="pubmed">9003192</ArticleId></ArticleIdList></Reference><Reference><Citation>Jumper J., Evans R., Pritzel A., Green T., Figurnov M., Ronneberger O., Tunyasuvunakool K., Bates R., Zidek A., Potapenko A.et al. .. Highly accurate protein structure prediction with alphafold. Nature. 2021; 596:583–589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8371605</ArticleId><ArticleId IdType="pubmed">34265844</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorrentino S. The eight human “canonical” ribonucleases: molecular diversity, catalytic properties, and special biological actions of the enzyme proteins. FEBS Lett. 2010; 584:2194–2200.</Citation><ArticleIdList><ArticleId IdType="pubmed">20388512</ArticleId></ArticleIdList></Reference><Reference><Citation>Rieder E., Paul A.V., Kim D.W., van Boom J.H., Wimmer E.. Genetic and biochemical studies of poliovirus cis-acting replication element cre in relation to VPg uridylylation. J. Virol. 2000; 74:10371–10380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC110911</ArticleId><ArticleId IdType="pubmed">11044081</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray K.E., Barton D.J.. Poliovirus CRE-dependent VPg uridylylation is required for positive-strand RNA synthesis but not for negative-strand RNA synthesis. J. Virol. 2003; 77:4739–4750.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC152113</ArticleId><ArticleId IdType="pubmed">12663781</ArticleId></ArticleIdList></Reference><Reference><Citation>Steil B.P., Barton D.J.. Conversion of VPg into VPgpUpUOH before and during poliovirus negative-strand RNA synthesis. J. Virol. 2009; 83:12660–12670.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2786823</ArticleId><ArticleId IdType="pubmed">19812161</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Ren J., Gao Q., Hu Z., Sun Y., Li X., Rowlands D.J., Yin W., Wang J., Stuart D.I.et al. .. Hepatitis a virus and the origins of picornaviruses. Nature. 2015; 517:85–88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4773894</ArticleId><ArticleId IdType="pubmed">25327248</ArticleId></ArticleIdList></Reference><Reference><Citation>Andino R., Rieckhof G.E., Achacoso P.L., Baltimore D. Poliovirus RNA synthesis utilizes an RNP complex formed around the 5′-end of viral RNA. EMBO J. 1993; 12:3587–3598.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC413634</ArticleId><ArticleId IdType="pubmed">8253083</ArticleId></ArticleIdList></Reference><Reference><Citation>Duke G.M., Hoffman M.A., Palmenberg A.C.. Sequence and structural elements that contribute to efficient encephalomyocarditis virus RNA translation. J. Virol. 1992; 66:1602–1609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC240893</ArticleId><ArticleId IdType="pubmed">1310768</ArticleId></ArticleIdList></Reference><Reference><Citation>Le S.Y., Chen J.H., Sonenberg N., Maizel J.V. Jr. Conserved tertiary structural elements in the 5′ nontranslated region of cardiovirus, aphthovirus and hepatitis a virus RNAs. Nucleic Acids Res. 1993; 21:2445–2451.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC309545</ArticleId><ArticleId IdType="pubmed">8389442</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagashima S., Sasaki J., Taniguchi K.. Functional analysis of the stem-loop structures at the 5′ end of the aichi virus genome. Virology. 2003; 313:56–65.</Citation><ArticleIdList><ArticleId IdType="pubmed">12951021</ArticleId></ArticleIdList></Reference><Reference><Citation>Belalov I.S., Isaeva O.V., Lukashev A.N.. Recombination in hepatitis a virus: evidence for reproductive isolation of genotypes. J. Gen. Virol. 2011; 92:860–872.</Citation><ArticleIdList><ArticleId IdType="pubmed">21216988</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa-Mattioli M., Ferre V., Casane D., Perez-Bercoff R., Coste-Burel M., Imbert-Marcille B.M., Andre E.C., Bressollette-Bodin C., Billaudel S., Cristina J.. Evidence of recombination in natural populations of hepatitis a virus. Virology. 2003; 311:51–59.</Citation><ArticleIdList><ArticleId IdType="pubmed">12832202</ArticleId></ArticleIdList></Reference><Reference><Citation>Lussi C., Schweizer M.. What can pestiviral endonucleases teach us about innate immunotolerance?. Cytokine Growth Factor Rev. 2016; 29:53–62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7173139</ArticleId><ArticleId IdType="pubmed">27021825</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K., Chen Z., Kato N., Gale M. Jr, Lemon S.M. Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J. Biol. Chem. 2005; 280:16739–16747.</Citation><ArticleIdList><ArticleId IdType="pubmed">15737993</ArticleId></ArticleIdList></Reference><Reference><Citation>Harak C., Lohmann V.. Ultrastructure of the replication sites of positive-strand RNA viruses. Virology. 2015; 479-480:418–433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7111692</ArticleId><ArticleId IdType="pubmed">25746936</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeghipour S., Bek E.J., McMinn P.C.. Selection and characterisation of guanidine-resistant mutants of human enterovirus 71. Virus Res. 2012; 169:72–79.</Citation><ArticleIdList><ArticleId IdType="pubmed">22814431</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolskaya E.A., Romanova L.I., Kolesnikova M.S., Gmyl A.P., Gorbalenya A.E., Agol V.I.. Genetic studies on the poliovirus 2C protein, an NTPase. A plausible mechanism of guanidine effect on the 2C function and evidence for the importance of 2C oligomerization. J. Mol. Biol. 1994; 236:1310–1323.</Citation><ArticleIdList><ArticleId IdType="pubmed">8126722</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadaschik D., Klein M., Zimmermann H., Eggers H.J., Nelsen-Salz B.. Dependence of echovirus 9 on the enterovirus RNA replication inhibitor 2-(alpha-Hydroxybenzyl)-benzimidazole maps to nonstructural protein 2C. J. Virol. 1999; 73:10536–10539.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC113111</ArticleId><ArticleId IdType="pubmed">10559374</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein M., Hadaschik D., Zimmermann H., Eggers H.J., Nelsen-Salz B.. The picornavirus replication inhibitors HBB and guanidine in the echovirus-9 system: the significance of viral protein 2C. J. Gen. Virol. 2000; 81:895–901.</Citation><ArticleIdList><ArticleId IdType="pubmed">10725414</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu H., Agoh M., Agoh Y., Yoshida H., Yoshii K., Yoneyama T., Hagiwara A., Miyamura T.. Mutations in the 2C region of poliovirus responsible for altered sensitivity to benzimidazole derivatives. J. Virol. 2000; 74:4146–4154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC111929</ArticleId><ArticleId IdType="pubmed">10756027</ArticleId></ArticleIdList></Reference><Reference><Citation>De Palma A.M., Heggermont W., Lanke K., Coutard B., Bergmann M., Monforte A.M., Canard B., De Clercq E., Chimirri A., Purstinger G.et al. .. The thiazolobenzimidazole TBZE-029 inhibits enterovirus replication by targeting a short region immediately downstream from motif c in the nonstructural protein 2C. J. Virol. 2008; 82:4720–4730.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2346740</ArticleId><ArticleId IdType="pubmed">18337578</ArticleId></ArticleIdList></Reference><Reference><Citation>Manganaro R., Zonsics B., Bauer L., Lorenzo Lopez M., Donselaar T., Zwaagstra M., Saporito F., Ferla S., Strating J., Coutard B.et al. .. Synthesis and antiviral effect of novel fluoxetine analogues as enterovirus 2C inhibitors. Antiviral Res. 2020; 178:104781.</Citation><ArticleIdList><ArticleId IdType="pubmed">32234539</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurdiss D.L., El Kazzi P., Bauer L., Papageorgiou N., Ferron F.P., Donselaar T., van Vliet A.L.W., Shamorkina T.M., Snijder J., Canard B.et al. .. Fluoxetine targets an allosteric site in the enterovirus 2C AAA+ ATPase and stabilizes a ring-shaped hexameric complex. Sci. Adv. 2022; 8:eabj7615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8730599</ArticleId><ArticleId IdType="pubmed">34985963</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L., Manganaro R., Zonsics B., Strating J., El Kazzi P., Lorenzo Lopez M., Ulferts R., van Hoey C., Mate M.J., Langer T.et al. .. Fluoxetine inhibits enterovirus replication by targeting the viral 2C protein in a stereospecific manner. ACS Infect. Dis. 2019; 5:1609–1623.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6747591</ArticleId><ArticleId IdType="pubmed">31305993</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulferts R., de Boer S.M., van der Linden L., Bauer L., Lyoo H.R., Mate M.J., Lichiere J., Canard B., Lelieveld D., Omta W.et al. .. Screening of a library of FDA-Approved drugs identifies several enterovirus replication inhibitors that target viral protein 2C. Antimicrob. Agents Chemother. 2016; 60:2627–2638.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4862474</ArticleId><ArticleId IdType="pubmed">26856848</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurdiss D.L., El Kazzi P., Bauer L., Papageorgiou N., Ferron F.P., Donselaar T., van Vliet A.L.W., Canard B., Decroly E., Brancale A.et al. .. Fluoxetine targets an allosteric site in the enterovirus 2C AAA+ ATPase and stabilizes the hexameric complex. Sci. Adv. 2022; 8:eabj7615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8730599</ArticleId><ArticleId IdType="pubmed">34985963</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Y., Wang C., Wang C., Yang R., Bai P., Zhang X.Y., Kong J., Yin L., Qiu Y., Zhou X.. Antiviral peptides targeting the helicase activity of enterovirus nonstructural protein 2C. J. Virol. 2021; 95:e02324-20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8315976</ArticleId><ArticleId IdType="pubmed">33789997</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>